Cynata Therapeutics Limited (CYYNF)
OTCMKTS
· Delayed Price · Currency is USD
0.1500
0.00 (0.00%)
At close: May 5, 2025
Cynata Therapeutics Revenue
Cynata Therapeutics had revenue of 1.97M AUD in the half year ending December 31, 2024, with 9.39% growth. This brings the company's revenue in the last twelve months to 1.74M, down -27.47% year-over-year. In the fiscal year ending June 30, 2024, Cynata Therapeutics had annual revenue of 2.32M with 39.98% growth.
Revenue (ttm)
1.74M AUD
Revenue Growth
-27.47%
P/S Ratio
25.58
Revenue / Employee
870.03K AUD
Employees
2
Market Cap
27.55M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 2.32M | 661.33K | 39.98% |
Jun 30, 2023 | 1.65M | -6.12M | -78.71% |
Jun 30, 2022 | 7.77M | 6.22M | 402.60% |
Jun 30, 2021 | 1.55M | -5.47M | -77.95% |
Jun 30, 2020 | 7.01M | 5.70M | 435.83% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Cynata Therapeutics News
- 3 months ago - Cynata Therapeutics Limited (CYYNF) Investor Webinar Transcript - Seeking Alpha
- 4 years ago - Mesoblast Needs A Solution To MSC Scalability Issues - Cynata Therapeutics Has An Answer - Seeking Alpha